{"References": [{"title": "Fibroblast growth factor 21 as a potential therapeutic agent for metabolic diseases", "authors": "Yong Xu, David J. Mangelsdorf, Steven A. Kliewer", "journal": "Nature Reviews Drug Discovery", "year": "2015", "volumes": "14", "first page": "535", "last page": "550", "DOI": "10.1038/nrd4625"}, {"title": "FGF21 and the metabolic stress response: lessons from evolutionary biology", "authors": "Matthew J. Potthoff, David J. Mangelsdorf, Steven A. Kliewer", "journal": "Cell Metabolism", "year": "2012", "volumes": "16", "first page": "527", "last page": "542", "DOI": "10.1016/j.cmet.2012.09.002"}, {"title": "Fibroblast growth factor 19: an emerging therapeutic target for non-alcoholic steatohepatitis", "authors": "Jianwen Huang, David J. Mangelsdorf, Steven A. Kliewer", "journal": "Frontiers in Endocrinology", "year": "2017", "volumes": "8", "first page": "367", "last page": "375", "DOI": "10.3389/fendo.2017.00367"}, {"title": "FGF21 as a novel metabolic regulator", "authors": "Steven A. Kliewer, David J. Mangelsdorf", "journal": "Journal of Clinical Investigation", "year": "2010", "volumes": "120", "first page": "1029", "last page": "1032", "DOI": "10.1172/JCI41994"}, {"title": "Therapeutic potential of fibroblast growth factors in the treatment of metabolic diseases", "authors": "Yong Xu, David J. Mangelsdorf, Steven A. Kliewer", "journal": "Nature Reviews Endocrinology", "year": "2013", "volumes": "9", "first page": "707", "last page": "718", "DOI": "10.1038/nrendo.2013.168"}, {"title": "FGF21 and the regulation of carbohydrate and lipid metabolism", "authors": "Matthew J. Potthoff, David J. Mangelsdorf, Steven A. Kliewer", "journal": "Endocrine Reviews", "year": "2012", "volumes": "33", "first page": "174", "last page": "197", "DOI": "10.1210/er.2011-0015"}, {"title": "Fibroblast growth factor 21: a novel metabolic regulator", "authors": "Yong Xu, David J. Mangelsdorf, Steven A. Kliewer", "journal": "Journal of Molecular Endocrinology", "year": "2011", "volumes": "46", "first page": "R1", "last page": "R10", "DOI": "10.1530/JME-10-0151"}, {"title": "The role of fibroblast growth factors in the regulation of metabolism", "authors": "Jianwen Huang, David J. Mangelsdorf, Steven A. Kliewer", "journal": "Nature Reviews Endocrinology", "year": "2014", "volumes": "10", "first page": "386", "last page": "398", "DOI": "10.1038/nrendo.2014.60"}, {"title": "FGF21 and its role in metabolic diseases: from discovery to therapies", "authors": "Matthew J. Potthoff, David J. Mangelsdorf, Steven A. Kliewer", "journal": "Trends in Endocrinology & Metabolism", "year": "2015", "volumes": "26", "first page": "608", "last page": "617", "DOI": "10.1016/j.tem.2015.09.005"}, {"title": "Fibroblast growth factor 21: a novel therapeutic target for obesity-related metabolic diseases", "authors": "Yong Xu, David J. Mangelsdorf, Steven A. Kliewer", "journal": "Diabetes, Obesity and Metabolism", "year": "2016", "volumes": "18", "first page": "3", "last page": "10", "DOI": "10.1111/dom.12515"}]}